Published in
Springer, Investigational New Drugs, 4(39), p. 1047-1056, 2021
DOI: 10.1007/s10637-021-01081-x
Links
Tools
First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies
Journal article published in 2021 by
Sarina A. Piha-Paul 
,
Kyaw Z. Thein,
Paul De Souza,
Richard Kefford ,
Tara Gangadhar,
Christopher Smith,
Shelly Schuster,
William C. Zamboni,
Claire E. Dees,
Ben Markman
,
Kyaw Z. Thein,
Paul De Souza,
Richard Kefford ,
Tara Gangadhar,
Christopher Smith,
Shelly Schuster,
William C. Zamboni,
Claire E. Dees,
Ben Markman
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 